The Efficacy and Safety of First-Line Chemotherapy in Patients With Non-small Cell Lung Cancer and Interstitial Lung Disease: A Systematic Review and Meta-Analysis.

Front Oncol · 2020 · PMC7506119 · PMID 33014824

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

In this study, carboplatin + paclitaxel was the main treatment regimen, whereas our study included new treatment regimens such as carboplatin + nab-paclitaxel and carboplatin + S-1; this implies that the difference in the incidence of AE-ILD between treatment regimens may not be significant.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.